← All stocks

Longeveron Inc.

LGVN Net buying
CIK 0001721484 #4934 in the set updated 22 Sep 2026
Bought (120 mo)
$2.89M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.30M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.30M
17 of 17 sales
Net
+$1.59M
+$1.59M against sales at will

By person

30 insiders · 46 transactions

There is no salary here to measure against. Longeveron Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Soffer Donald M
Director
$1.00M (1)
+$1.00M
21,490,847
$26.86M
−5.0%
Hare Joshua
Chief Scientific Officer
$1.40M (7)
$728.84K (6)
+$675.55K
10,811,369
$13.51M
+12.2%
Clavijo James
CFO and Treasurer
$16.70K (1)
$386.79K (4)
−$370.09K
47,303
$59.13K
−49.5%
Soffer Rock
Director
$398.66K (6)
$182.03K (6)
+$216.64K
964,385
$1.21M
+894.3%
Hashad Mohamed Wa'el Ahmed
Chief Executive Officer
$25.00K (1)
+$25.00K
510,681
$638.35K
+5,588%
PFEFFER JEFFREY
Director
$13.50K (1)
+$13.50K
15,000
$18.75K
Baluch Khoso
Director
$14.26K (3)
$2.59K (1)
+$11.67K
67,391
$84.24K
+4,393%
Ross Cathy
Director
$6.54K (1)
+$6.54K
10,000
$12.50K
Lehr Paul T
General Counsel, Secretary
$5.85K (1)
+$5.85K
1,003,829
$1.25M
+521.8%
Green Geoff
CEO
$3.81K (1)
+$3.81K
133,904
$167.38K
−23.2%
Locklear Lisa
Chief Financial Officer
(1)
$0.00
480,005
$600.01K
+12,933%
Willard Stephen H
Chief Executive Officer
771,681
$964.60K
Agafonova Nataliya
Chief Medical Officer
737,700
$922.13K
+35,383%
Blass Devin
CTO & SVP of CMC
711,735
$889.67K
+487.8%
Jhaveri Nirav S.
Chief Financial Officer
300,000
$375.00K
Min Kwan-Hong Christopher
Chief Medical Officer
152,335
$190.42K
Powell James Nathaniel
Chief Executive Officer
125,593
$156.99K
+56.1%
Hare Neil E
Director
88,760
$110.95K
+47.3%
Ungaro Ursula
Director
82,000
$102.50K
+16,300%
Paletta George A. Jr.
Director
70,000
$87.50K
Hajjar Roger Joseph
Director
69,000
$86.25K
Desai Arjun JJ
Director
36,000
$45.00K
Cann Leah Rush
Director
36,000
$45.00K
Ascheim Deborah
Director
36,000
$45.00K
Kender Richard N
Director
33,000
$41.25K
Motwani Neha J.
Director
33,000
$41.25K
Borger Erin
Director
22,836
$28.55K
0.0%
Girolamo Todd C
Director
5,000
$6.25K
LOSORDO DOUGLAS W
Director
5,000
$6.25K
DS MED LLC entity
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 1,651.0 over the window, from 15,013,072 to 24,786,282,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 206
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 17
Transactions with no price 2
Shares from compensation/vesting 30,382,881
Sales filed before the plan box existed 9
History held since 17 Feb 2021